Table I.
N (%) | |
---|---|
Male/Female | 15/6 |
Median Age (Range) | 7.5 (0.8 – 25.6) years |
Stage at Diagnosis | |
1 | 1 (5%) |
3 | 1 (5%) |
4 | 19 (90%) |
Tumor Biology at Diagnosis | |
MYCN amplified | 5 (24%) |
MYCN non-amplified | 14 (67%) |
Unknown/not done | 2 (10%) |
Favorable histology | 0 (0%) |
Unfavorable histology | 14 (67%) |
Unknown/not done | 7 (33%) |
Prior Therapies | |
Chemotherapy | 21 (100%) |
XRT | 16 (76%) |
HDT/SCR | 13 (62%) |
MIBG Therapy | 7 (33%) |
History of Tumor Relapse prior to Study Entry |
21 (100%) |